Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

METOCLOPRAMIDE SYRUP 5 mg/5 ml

Approval Number

SIN03349P

Drug Name

METOCLOPRAMIDE SYRUP 5 mg/5 ml

Product Name

METOCLOPRAMIDE SYRUP 5 mg/5 ml

Approval Date

June 16, 1989

Registrant

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Licence Holder

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

Registrant

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Licence Holder

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

SYRUP

Route of Administration

ORAL

Medical Information

ATC Code

A03FA01

ATC Item Name

metoclopramide

Manufacturer Information

Pharmaceutical Manufacturer

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Manufacturers

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL SDN BHD

Active Ingredients

Ingredient Name

METOCLOPRAMIDE HCl EQV ANHYDROUS METOCLOPRAMIDE HCl

Strength

5 mg/5 ml

Drug MonographMetoclopramide

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

METOCLOPRAMIDE SYRUP 5 mg/5 ml - HSA Approval | MedPath